Investigator-sponsored study funded by the French National Cancer Institute (INCa) meets pre-specified primary efficacy success criterion with ...

A large SEER database analysis presented at the American College of Surgeons Clinical Congress 2026 shows that patients aged ...

A Bayesian network meta-analysis of ten randomized trials finds that fruquintinib, regorafenib, and TAS-102 all extend ...

Researchers at Hokkaido University, in collaboration with an international team of scientists led by the University of South Florida Health and Tampa General Hospital, have uncovered an important ...

Colorectal cancer most often spreads to the liver. When those liver tumors (called liver metastases) can be removed with ...

(XBIT), a biotechnology company developing therapeutic antibodies, announced positive final efficacy results from the Phase 2 portion of the investigator-sponsored TASKIN trial evaluating vilamakitug ...

PDS Biotechnology (NASDAQ:PDSB) outlined plans to advance its investigational immunocytokine PDS0301 into a Phase III study ...

Nanjing Leads Biolabs Co., Ltd. Class H ( (HK:9887) ) just unveiled an update.

Metastatic colorectal cancer (mCRC) continues to increase among patients 45 and younger. Their longer survival and different disease patterns compared with older patients may warrant closer scrutiny ...

The Metastatic Colorectal Cancer Clinical Trials analysis report delivers important insights into ongoing research of 150+ pipeline Metastatic Colorectal Cancer Drugs, clinical strategies, upcoming ...